Table 3.
EPD Group, N (%) | Control Group, N (%) | |||
---|---|---|---|---|
Improved | 7 (16) | 4 (22) | ||
Unchanged | 11 (68) | 13 (72) | ||
Decreased | 0 (0) | 1 (6) | ||
Baseline | Follow-up | Baseline | Follow-up | |
Serum creatinine (mg/dL) | 2.15 ± 0.72 | 1.99 ± 0.58 | 2.15 ± 0.64 | 2.11 ± 0.98 |
eGFR (mL/min) | 34.8 ± 13.6 | 36.0 ± 13 | 33.6 ± 12.8 | 35.8 ± 13.7 |
KDOQI class 2 | 0 | 0 | 1 | 2 |
3A | 5 | 5 | 3 | 2 |
3B | 6 | 8 | 8 | 6 |
4 | 7 | 4 | 7 | 6 |
5 | 1 | 0 | 0 | 0 |
Hemodialysis | NA | 2 | NA | 3 |
Deaths | NA | 5 | NA | 5 |
Abbreviations: EPD, embolic protection device; KDOQI, Kidney Disease Outcome and Quality Initiative; NA, not applicable.